Lisa Perry

Biography

 Lisa Perry is the Business Unit Director for Oncology at AstraZeneca Australia. In this role she is responsible for the products in this portfolio and for the sales and marketing teams working within this therapy area. Lisa commenced with AstraZeneca in February 2015. Prior to joining the company, Lisa worked at Merck Serono where she most recently held the role of Regional Franchise Leader Oncology, Asia Pacific. Immediately prior, she was Business Unit Director for Oncology in Australia. Lisa started her career as a Nurse, transitioning to clinical research roles. She then held medical and marketing roles in Cardiovascular before moving into Oncology in 2004 - initially with Aventis and then moving to Merck Serono in 2006. Lisa has a proven track record in leading people and has extensive experience in Oncology. She has worked across a range of tumour types, including breast, prostate, colorectal, lung, non-small cell lung cancer, and head and neck at various stages of the product lifecycle.

Research Interest

 Cancer